AMBER TAYLOR: Open Payments
NPI 1679019434 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 32 payments from 10 companies in 2025. Trend: 2023 $1,946 · 2024 $264 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC | 4 | $253 |
| ABBVIE INC. | 8 | $169 |
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Endo USA, Inc. | 4 | $106 |
| TOLMAR, INC. | 3 | $78 |
| Myriad Genetic Laboratories, Inc. | 2 | $61 |
| 180 Medical, Inc. | 2 | $43 |
| Antares Pharma, Inc. | 2 | $28 |
| Medtronic, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: UROLIFT, BOTOX, GEMTESA, PROLARIS, AVEED, JATENZO, XIAFLEX, BARRIGEL.
Industry payments across TX — which companies pay providers there.
